Mode
Text Size
Log in / Sign up
N/A N=189 Diagnostic

Comparative Study of Conventional MR Images With Synthetically Reconstructed MR Images of the Brain

Clinical Indication for Brain MRI · Healthy Volunteers

Enrolled (actual)
189
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcome: Primary: Sensitivity of Pathological Findings (Full Analysis Set) — 0.66; 0.68 Proportion of participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
SyMRI 15 (3D) (Device)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
SyntheticMR
Primary completion
Feb 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Sensitivity of Pathological Findings (Full Analysis Set)
0.66; 0.68
PRIMARY
Specificity of Pathological Findings (Full Analysis Set)
0.85; 0.85
SECONDARY
Classification of Pathological Findings
0.60; 0.60
SECONDARY
Sensitivity (Adult Population)
0.68; 0.70
SECONDARY
Selectivity (Adult Population)
0.84; 0.84
SECONDARY
Classification of Pathological Findings (Adult Population)
0.61; 0.61
SECONDARY
Sensitivity (Pediatric Population)
0.64; 0.64
SECONDARY
Selectivity (Pediatric Population)
0.90; 0.87
SECONDARY
Classification of Pathological Findings (Pediatric Population)
0.57; 0.58

Summary

This study is being conducted for evaluation of 3D Synthetic MRI (SyMRI 15, 3D) for neuroimaging,

Eligibility Criteria

Inclusion Criteria

  • Any gender, aged 0-99 years
  • Subject scheduled for MRI of the brain OR Healthy control with passed screening form
  • Subject suitable for MRI as judged by investigator
  • Subject agrees to 5-20 min extra MRI scan time
  • Subject able to understand written and verbal information in English or Spanish
  • Provision of informed consent (and assent if applicable)

Exclusion Criteria

  • Have contraindication(s) to MRI scanning per the routine MR Safety Screening policy of the investigational site
  • Have severe trauma, disability or pre-existing pathology that is expected to interfere with normal conduct of MRI scanning or complete scanning of the brain
  • Have medical condition(s) such as those requiring urgent medical care that, in the opinion of a physician investigator, would prevent safe participation in the study
  • Adult subjects (aged 18-99 years) in need of anesthesia during MRI scanning
  • Pregnancy at time of enrollment determined according to the clinic's MR Safety Screening policy
  • Previous enrollment in this investigation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05425927). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search